×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DXR – daxor corporation (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DXR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/11
10:13 am
dxr
Daxor (NASDAQ:DXR) is now covered by analysts at Lake Street Capital. They set a "buy" rating on the stock.
Low
Report
Daxor (NASDAQ:DXR) is now covered by analysts at Lake Street Capital. They set a "buy" rating on the stock.
2/10
08:00 am
dxr
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business
Low
Report
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business
1/23
08:00 am
dxr
Daxor Corporation Announces $9 Million Registered Direct Offering
Medium
Report
Daxor Corporation Announces $9 Million Registered Direct Offering
11/25
08:00 am
dxr
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
High
Report
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
1/26
04:59 pm
dxr
Form 8-K DAXOR CORP For: Jan 23
Medium
Report
Form 8-K DAXOR CORP For: Jan 23
1/23
06:09 am
dxr
Form 8-K DAXOR CORP For: Jan 23
Medium
Report
Form 8-K DAXOR CORP For: Jan 23
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/28
Form N-CSR DAXOR CORP For: Dec 31
65.7%
3/20 Daxor Corporation’s BVA-100® Test Used to Guide Treatment In COVID-19 Patient 28.0%
3/4 3 Biotech Stocks Join the Coronavirus Fight; Analysts Weigh In [Yahoo! Finance News] 13.0%
5/30 Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice 12.8%
4/23 Form 8-K DAXOR CORP For: Apr 23 7.6%
8/27 Form N-CSRS DAXOR CORP For: Jun 30 5.7%
8/6 Daxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific Northwest 3.5%
11/21 Novel Study from Yale University Utilizes Daxor’s Blood Volume Analyzer (BVA-100®) to Uncover Important Mechanism for Drug Empagliflozin 3.1%
9/19 Form 40-17F2 DAXOR CORP Filed by: DAXOR CORP 2.6%
6/3 Form DEFR14A DAXOR CORP 2.5%
3/20 Daxor Corporation’s BVA-100® Test Used to Guide Treatment In COVID-19 Patient 28.0%
3/4 3 Biotech Stocks Join the Coronavirus Fight; Analysts Weigh In [Yahoo! Finance News] 13.0%
5/30 Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice 12.8%
4/23 Form 8-K DAXOR CORP For: Apr 23 7.6%
8/27 Form N-CSRS DAXOR CORP For: Jun 30 5.7%
8/6 Daxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific Northwest 3.5%
11/21 Novel Study from Yale University Utilizes Daxor’s Blood Volume Analyzer (BVA-100®) to Uncover Important Mechanism for Drug Empagliflozin 3.1%
9/19 Form 40-17F2 DAXOR CORP Filed by: DAXOR CORP 2.6%
6/3 Form DEFR14A DAXOR CORP 2.5%
TOP News Decliners
3/9
Daxor Corporation Contracted to Adapt Its Blood Volume Analyzer Technology for U.S. Air Force Needs
-17.6%
4/23 Daxor up 4% on DoD contract for portable blood volume analyzer [Seeking Alpha] -15.2%
3/13 Form N-CEN DAXOR CORP For: Dec 31 -14.2%
3/3 Daxor Corporation Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market -8.2%
6/24 Form 40-APP DAXOR CORP -8.1%
4/30 Form POS 8C DAXOR CORP -8.1%
5/17 Form POS 8C DAXOR CORP -7.8%
11/12 Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2019 -5.1%
9/11 Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America -3.8%
9/24 Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension -3.3%
4/23 Daxor up 4% on DoD contract for portable blood volume analyzer [Seeking Alpha] -15.2%
3/13 Form N-CEN DAXOR CORP For: Dec 31 -14.2%
3/3 Daxor Corporation Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market -8.2%
6/24 Form 40-APP DAXOR CORP -8.1%
4/30 Form POS 8C DAXOR CORP -8.1%
5/17 Form POS 8C DAXOR CORP -7.8%
11/12 Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2019 -5.1%
9/11 Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America -3.8%
9/24 Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension -3.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: